Average Co-Inventor Count = 4.41
ph-index = 27
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Epizyme, Inc. (85 from 158 patents)
2. Envivo Pharmaceuticals, Inc. (12 from 13 patents)
3. Forum Pharmaceuticals, Inc. (8 from 9 patents)
4. Methylgene, Inc. (2 from 53 patents)
5. Other (1 from 832,680 patents)
6. Eisai R&d Management Co., Ltd. (1 from 527 patents)
7. Glaxosmithkline Intellectual Property Development Limited (1 from 230 patents)
8. Ironwood Pharmaceuticals, Inc. (1 from 44 patents)
9. Axovant Sciences Gmbh (8 patents)
107 patents:
1. 12168016 - Aryl-OR heteroaryl-substituted benzene compounds
2. 12168015 - Aryl-or heteroaryl-substituted benzene compounds
3. 12161645 - Aryl-or heteroaryl-substituted benzene compounds
4. 11834455 - Carm1 inhibitors and uses thereof
5. 11633420 - Method of treating leukemia
6. 11512053 - Arginine methyltransferase inhibitors and uses thereof
7. 11185531 - Arginine methyltransferase inhibitors and uses thereof
8. 11052093 - Aryl-or heteroaryl-substituted benzene compounds
9. 10980794 - PRMT5 inhibitors and uses thereof
10. 10881680 - Method of treating leukemia
11. 10800743 - Arginine methyltransferase inhibitors and uses thereof
12. 10669243 - Isoxazole carboxamides as irreversible SMYD inhibitors
13. 10653693 - PRMT5 inhibitors and uses thereof
14. 10632103 - Arginine methyltransferase inhibitors and uses thereof
15. 10633389 - CARM1 inhibitors and uses thereof